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The attempted ethenylation at C(2) of 2-unsubstituted imidazole N-oxides with 
ethyl acrylate in the presence of Pd(OAc)2 does not occur. In contrast to the other 
aromatic N-oxides, the [2+3] cycloaddition of imidazole N-oxides predominates, and 3-
hydroxyacrylates, isomeric with the cycloadducts, are key products for the subsequent 
reaction course. The final products were identified as dehydrated 2+1 adducts of 
imidazol N-oxide and ethyl acrylate. The role of the catalyst is limited to the 
dehydration of the intermediate 3-hydroxypropanoates to give imidazol-substituted 
acrylates. 
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1. Introduction. –  In recent years, a series of reports on the synthesis and 
applications of 2-unsubstituted imidazole 3-oxides 1 was published. In contrast to six-
membered aromatic heterocyclic N-oxides, they cannot be prepared by direct oxidation 
of the parent system, but the condensation of α-hydroxyiminoketones with methylidene 
amines offers a convenient access to this group of reactive imidazole derivatives [1][2]. 
One of the most characteristic features of their structure is the ‘nitrone-like’ pattern, 
which enables diverse 1,3-dipolar cycloadditions with electron-deficient acetylenes and 
ethenes as well as isocyanates and thiocarbonyl compounds [2][3]. The initially formed 
[2+3] cycloadducts have never been isolated, and secondary processes occur leading to 
the products depicted in Scheme 1. 
 
Scheme 1 
 
On the other hand, the C(2)-position of 1 can easily be arylated in the presence 
of Pd(OAc)2 with preservation of the N-oxide function [4]. The conversion of N-oxides 
1 into the corresponding imidazoles occurs smoothly upon treatment with Raney-Ni at 
room temperature [5]. 
The metal-catalyzed formation of new C,C-bonds in aromatic and 
heteroaromatic rings is a challenging task in modern organic synthesis, and the state of 
the art in the field of imidazole derivatives has recently been summarized [6]. A 
frequently studied reaction is the ethenylation with acrylates leading to 3-aryl 
propenoates. Despite the potential importance of ethenylations of aromatic N-oxides, 
there are, to the best of our knowledge, only two reports known on Pd-catalyzed 
reactions of this type (Scheme 2). In one case, pyridine N-oxides 2 were converted 
regioselectively into 3-(pyridin-2-yl) propenoates 3 with a preserved N-oxide group in 
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high yield [8]. The second reaction reported is the transformation of quinoline N-oxides 
4 into the propenoates 5. In these reactions, a spontaneous deoxygenation of the N-oxide 
occurred [9]. 
 
Scheme 2 
 
In a recent report, the synthesis of 2-hydroxy-3-(isoquinolin-1-yl)propanoates 6 
was described, formed via the in situ generated isoquinoline N-oxide and acrylates in 
the presence of LiOH as a base [9] (Scheme 3). It is worth mentioning that this reaction 
proceeds without transition metal-catalysis. 
 
Scheme 3 
 
Thermal [2+3] cycloadditions of acrylates with aromatic N-oxides, which in 
general are recognized as poor 1,3-dipoles, are almost unknown. Huisgen and 
coworkers have shown that phenanthridine N-oxide and ethyl acrylate react in DMF 
solution at 75° to give products of type 6 [10]. The formation of the latter has been 
rationalized by a [2+3] cycloaddition, followed by a spontaneous ring opening of the 
intermediate isoxazolidine. In addition, the reaction of quinoline N-oxide with 2-
methylacrylonitrile to produce an analogous ring opened product identified as 2-
hydroxy-2-methyl-3-(quinolin-2-yl)propionitrile has been reported [11]. 
Prompted by the results described in [7] and [8], we decided to study the 
reaction of ethyl acrylate with 2-unsubstituted imidazole 3-oxides 1 both in the presence 
and in the absence of a catalytic amount of Pd(AcO)2.  
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Results and Discussion. – In a preliminary experiment, equimolar amounts of 
ethyl acrylate and 1-methyl-4,5-diphenylimidazole 3-oxide (1a) were dissolved in 
CHCl3. No reaction took place at room temperature nor when the solution was heating 
to reflux. Therefore, the starting 1a and a 5-fold excess of acrylate were dissolved in N-
methylpyrrolidone (NMP), and the solution was heated in an oil bath (110°). After ca. 1 
h, the reaction was stopped and chromatographic workup led to an oily product. The 
spectroscopic data confirmed the structure of the 3-hydroxypropanoate 7a (Scheme 4). 
Analogous products 7b – 7d were obtained with 1-ethyl-, 1-propyl-, and 1-allyl-4,5-
diphenyl imidazole 3-oxides in 26–33% yield. Attempted experiments with the 
corresponding 4,5-dimethyl- or 4-methyl-5-phenyl imidazole 3-oxides led to complex 
mixtures of products. 
 
Scheme 4 
 
The formation of the β-hydroxyesters 7 can be explained plausibly by an initial 
[2+3] cycloaddition to give 8 and subsequent opening of the isoxazolidine ring via 
cleavage of the N–O bond and aromatization of the imidazole unit. 
In order to achieve the ethenylation product of 1a, a similar experiment with 
ethyl acrylate was carried out in the presence of 5 mol% of Pd(OAc)2. After ca. 1 h, an 
analogous result was obtained as in the absence of the catalyst. When the reaction time 
was extended to 2.5 h, no 7a was present in the mixture. Chromatographic workup 
afforded a crystalline material, which showed signals from two MeN and only one EtO 
groups in the 1H-NMR spectrum. These data suggested that the new product contains 
two imidazole units and one propanoate fragment. The HR-MS showed the [M+1] peak 
at m/z 583.2700, which corresponds to a structure formed from two molecules 1a and 
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one molecule of ethyl acrylate after elimination of H2O. Finally, an X-ray crystal 
structure determination disclosed unambiguously the molecular structure of product 9a, 
which formally corresponds to a Michael adduct of 1-methyl-4,5-diphenyl imidazol-2-
one (10a) with 2-(imidazol-2-yl)acrylate 11a (Scheme 5, Figure). Most likely, the latter 
compound is formed in situ by dehydration of 7a. The imidazolone 10a can be formed 
in situ via thermal isomerization of 1a [13]. The analogous reaction course leading to 
products 9 was observed starting with 1b – 1d. 
 
Scheme 5 
 
Figure. ORTEP plot [12] of the molecular structure of 9a (with 50% probability 
ellipsoids; arbitrary numbering of the atoms).  
 
In order to get additional support for the proposed reaction mechanism, three 
control experiments were carried out. Firstly, the isolated hydroxyester 7b was 
dehydrated in NMP solution at 110° in the absence as well as in the presence of 
catalytic amounts of Pd(OAc)2. After 1 h, the progress of the reaction in both cases was 
examined by 1H-NMR spectroscopy. Whereas the reaction performed in the presence of 
Pd(OAc)2 was complete, yielding 11b exclusively, the reaction without Pd(OAc)2 gave 
11b only in traces, and more than 90% of 7b were still present in the mixture. Secondly, 
a mixture of the isolated 11b and imidazolone 10b (R = Et) were heated in NMP in the 
presence of catalytic amounts of Pd(OAc)2. After 2 h, the 1H-NMR spectrum of the 
mixture showed the presence of unchanged substrates, and no 9b could be detected. In 
the third experiment, equimolar amounts of 11b and 1a (R = Me) were heated in NMP 
solution at 110º in the absence of Pd(OAc)2. After 1 h, the mixture was analyzed by 1H-
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NMR spectroscopy. However, also in this case, no traces of the expected ‘mixed 
product’ of type 9 were found in the mixture. 
These results show that the formation of products 9 does not result from the 
reaction of 11 either with isolated imidazolones 10 or with N-oxides 1. Therefore, the 
formulation of a convincing mechanism of a cascade reaction leading to the Michael 
adducts of type 9 is not possible at the moment.  
 
3. Conclusions. – The present study shows that 2-unsubstituted imidazole N-
oxides, in contrast to quinoline and pyridine N-oxides, do not undergo the ethenylation 
reaction with ethyl acrylate in the presence of Pd(OAc)2. The obtained results show that 
under the applied conditions the preferred reaction is the [2+3] cycloaddition, which 
occurs regioselectively, leading to 3-hydroxypropanoate, which is a product of the 
spontaneous ring-opening of the five-membered cycloadduct. It is worth mentioning 
that the structures of the isolated hydroxyesters 7 do not correspond with those of 
products of analogous reactions with isoquinoline and quinoline N-oxides, respectively 
[9–11]. The catalyst used in the reaction accelerates the dehydration of the 
hydroxyester, formed after ring opening of the initial isoxazolidine derivative.  
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1. General. M.p.: MEL-TEMP. II (Aldrich); uncorrected. IR Spectra: NEXUS 
FT-IR instrument; in KBr or as film; absorptions in cm–1. 1H-NMR and 13C-NMR 
Spectra: BRUKER AVANCE III instrument (1H at 600 and 13C at 150 MHz) using 
solvent signal as reference; in CDCl3; chemical shifts (δ) in ppm; coupling constants J 
in Hz. The majority of the 13C signals were assigned with the aid of DEPT spectra. ESI-
HR-MS: Finnigan MAT-95 spectrometer.  
2. Starting Materials. The used reagents and solvents such as ethyl acrylate, 
Pd(II)(OAc)2, N-methylpyrrolidone (NMP), petroleum ether, Et2O, diisopropyl ether, 
pentane, and AcOEt are commercially available. Imidazole N-oxides 1 were prepared 
according to known protocols [13]. 
3. Reactions of 2-Unsubstituted Imidazole N-Oxides with Ethyl Acrylate. A 
mixture of the corresponding imidazole N-oxide 1 (1 mmol), ethyl acrylate (5 mmol), 
Pd(OAc)2 (5 mol%), and N-methylpyrrolidone (1 ml), used as a solvent, was heated 
under Ar in an oil bath at 110º for 40–45 min. After evaporation of the solvent and 
excess ethyl acrylate by vacuum distillation (bulb-to-bulb), the obtained residues were 
separated on prep. TLC plates (SiO2; hexane or petroleum ether/AcOEt 1:1) to give 
products 7 as pale yellow oils. Analogous results were obtained when the reactions were 
carried out without the addition of catalytic amounts of Pd(OAc)2.  
When the reactions were carried out for 2 – 2.5 h, no 3-hydroxypropanoates 7 
were present in the crude mixtures. Separation by prep. TLC gave solid materials 
identified as products 9, which subsequently were purified by crystallization from 
mixtures of petroleum ether or pentane with small amounts of Et2O or diisopropyl ether. 
 
 Ethyl 3-Hydroxy-2-(1-methyl-4,5-diphenylimidazol-2-yl)propanoate (7a). Yield: 
98 mg (28%). Pale yellow oil. IR (film): 3355 (OH), 3062, 2981, 2959, 2934, 2248, 
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1733 (C=O), 1603, 1507, 1465, 1443, 1301, 1243, 1185, 1072, 1055, 1044, 910, 732, 
700, 648. 1H-NMR (CDCl3): 1.34 (t, 3H, JH,H ≈ 7.1, MeCH2O); 3.35 (s, 3H, MeN); 3.92 
(t, 1H, JH,H ≈ 4.0, HOCH2CH); 4.25–4.35 (m, 2H, MeCH2O); 4.46 (d, 2H, JH,H ≈ 4.0, 
HOCH2CH); 5.16 (br. s, 1H, OH); 7.14–7.52 (m, 10 arom. CH). 13C-NMR (CDCl3): 
14.2 (MeCH2O); 31.0 (MeN); 45.9 (HOCH2CH); 61.7, 63.5 (2 CH2O); 126.4, 126.6, 
128.1, 128.8, 129.1, 130.9 (10 arom. CH); 129.4, 130.8, 134.2, 136.3 (2 arom. C, C(4), 
C(5)); 143.9 (C(2)), 169.8 (C=O). HR-ESI-MS: 351.1730 ([M+H]+; C21H23N2O3+; calc. 
351.1703).  
 Ethyl 2-(1-Ethyl-4,5-diphenylimidazol-2-yl)-3-hydroxypropanoate (7b). Yield: 
120 mg (33%). Pale yellow oil. IR (film): 3355 (OH), 3057, 2982, 2937, 2875, 2305, 
1736 (C=O), 1603, 1507, 1473, 1446, 1327, 1266, 1181, 1072, 1045, 1029, 955, 738, 
774, 700. 1H-NMR (CDCl3): 1.14 (t, 3H, JH,H ≈ 7.2, MeCH2N); 1.34 (t, 3H, JH,H ≈ 7.0, 
MeCH2O); 3.77–3.84 (m, 2H, MeCH2N); 3.92 (t, 1H, JH,H ≈ 4.0, HOCH2CH); 4.21–4.34 
(m, 2H, MeCH2O); 4.42 (d, 2H, JH,H ≈ 4.0, HOCH2CH); 5.22 (br. s, 1H, OH); 7.14–7.52 
(m, 10 arom. CH). 13C-NMR (CDCl3): 14.2 (MeCH2O); 15.9 (MeCH2N); 38.7 
(MeCH2N); 45.8 (HOCH2CH); 61.7, 62.9 (2 CH2); 126.3, 126.5, 128.0, 128.9, 129.1, 
131.1 (10 arom. CH); 128.6, 131.2, 134.2, 136.6 (2 arom. C, C(4), C(5)); 143.2 (C(2)); 
170.1 (C=O). HR-ESI-MS: 365.1870 ([M+H]+; C22H25N2O3+; calc. 365.1860).  
 Ethyl 2-(4,5-Diphenyl-1-propylimidazol-2-yl)-3-hydroxypropanoate (7c). Yield: 
110 mg (29%). Pale yellow oil. IR (film): 3351 (OH), 3060, 2970, 2935, 2876, 1736 
(C=O), 1603, 1507, 1470, 1445, 1369, 1239, 1179, 1073, 1046, 1028, 968, 775, 699. 
1H-NMR (CDCl3): 0.78 (t, 3H, JH,H ≈ 7.4, MeCH2CH2N); 1.34 (t, 3H, JH,H ≈ 7.1, 
MeCH2O); 1.47–1.54 (m, 2H, MeCH2CH2N); 3.68–3.71 (m, 2H, CH2N); 3.93 (t, 1H, 
JH,H ≈ 4.2, HOCH2CH); 4.27–4.32 (m, 2H, MeCH2); 4.43 (d, 2H, JH,H ≈ 4.2, 
HOCH2CH); 5.18 (br. s, 1H, OH); 7.13–7.51 (m, 10 arom. CH). 13C-NMR (CDCl3): 
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11.0 (MeCH2CH2N); 14.2 (MeCH2); 23.8 (MeCH2CH2N); 45.5 (CH2N); 45.9 
(HOCH2CH); 61.5, 62.9 (2 CH2); 126.3, 126.5, 128.0, 128.8, 129.1, 131.1 (10 arom. 
CH); 128.0, 131.2, 134.2, 136.5 (2 arom. C, C(4), C(5)); 143.5 (C(2)); 170.1 (C=O). 
HR-ESI-MS: 379.2013 ([M+H]+, C23H27N2O3+; calc. 379.2016).  
Ethyl 2-(1-Allyl-4,5-diphenylimidazol-2-yl)-3-hydroxypropanoate (7d). Yield: 
100 mg (27%). Pale yellow oil. IR (film): 3366 (OH), 3058, 2982, 2936, 2868, 1736 
(C=O), 1603, 1508, 1462, 1444, 1370, 1328, 1266, 1181, 1100, 1044, 1030, 924, 775, 
738, 701. 1H-NMR (CDCl3): 1.34 (t, 3H, JH,H ≈ 7.1, MeCH2O); 3.86 (t, 1H, JH,H ≈ 4.1, 
HOCH2CH); 4.24–4.31 (m, 2H, MeCH2O); 4.34–4.37 (m, 2H, HOCH2CH); 4.38–4.42 
(m, 2H, CH2N); 4.92 (dd, 1H, JH,H ≈ 17.0, 0.7, CH2=CH); 5.20 (dd, 1H, JH,H ≈ 10.0, 0.7, 
CH2=CH); 5.77–5.85 (m, 1H, CH2=CH); 7.14–7.50 (m, 10 arom. CH). 13C-NMR 
(CDCl3): 14.2 (MeCH2); 45.7 (HOCH2CH); 45.9 (CH2N); 61.7, 62.8 (2 CH2); 117.1 
(HOCH2CH); 126.4, 126.6, 128.1, 128.9, 129.0, 131.0, 132.9 (10 arom. CH, CH=CH2); 
128.0, 131.2, 134.2, 136.5 (2 arom. C, C(4), C(5)); 143.5 (C(2)); 170.0 (C=O). HR-ESI-
MS: 377.1860 ([M+H]+, C23H25N2O3+; calc. 377.1864).  
 Ethyl 2-(1-Methyl-4,5-diphenylimidazol-2-yl)-3-(3-methyl-2-oxo-4,5-diphenyl-
imidazol-1-yl)propanoate (9a). Yield: 60 mg (21%). Pale yellow crystals. M.p. 193–
195° (petroleum ether/diisopropyl ether). IR (KBr): 3057, 2978, 2954, 1736 (C=O), 
1684 (C=O), 1602, 1505, 1452, 1395, 1368, 1297, 1208, 1156, 1072, 1025, 918, 852, 
777, 700, 615, 505. 1H-NMR (CDCl3): 1.23 (t, 3H, JH,H ≈ 7.1, MeCH2O); 3.22 (s, 3H, 
MeN); 3.35 (s, 3H, MeN); 4.09–4.14 (m, 1H, MeCH2O); 4.17–4.23 (m, 1H, MeCH2O); 
4.42 (dd, JH,H ≈ 14.0, 8.2, 1H, CH2N); 4.58 (dd, 1H, JH,H ≈ 14.0, 7.0, CH2N); 4.90 (t, 
JH,H ≈ 7.5, 1H, CH2CH); 7.07–7.22 (m, 20 arom. CH). 13C-NMR (CDCl3): 14.1 
(MeCH2); 28.8, 31.1 (2 MeN); 42.1 (CH2CH); 42.6 (CH2N); 61.4 (MeCH2); 126.0, 
126.8, 127.9, 128.0, 128.4, 128.5, 129.0, 130.1, 130.6, 130.9 (20 arom. CH); 121.5, 
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121.6, 128.6, 129.0, 129.5, 131.3, 134.7, 137.0, 142.5 (4 arom. C, 2 C(4), 2 C(5), C(2)); 
153.9, 169.6 (2 C=O). HR-ESI-MS: 583.2700 ([M+H]+, C37H35N4O3+; calc. 583.2703).  
Crystals of 9a suitable for the X-ray crystal-structure determination were grown 
from CH2Cl2/diisopropyl ether. 
Ethyl 2-(1-Ethyl-4,5-diphenylimidazol-2-yl)-3-(3-ethyl-2-oxo-4,5-diphenyl-
imidazol-1-yl)propanoate (9b). Yield: 70 mg (23%). Pale yellow crystals. M.p. 165–
168° (petroleum ether/Et2O). IR (KBr): 3063, 2979, 2934, 1744 (C=O), 1674 (C=O), 
1602, 1506, 1446, 1407, 1352, 1302, 1229, 1201, 1061, 1027, 958, 862, 772, 700, 609, 
542. 1H-NMR (CDCl3): 1.06–1.14 (m, 6H, 2 MeCH2N); 1.23 (t, 3H, JH,H ≈ 7.1, 
MeCH2O); 3.66–3.72 (m, 1H, MeCH2O); 3.72–3.77 (m, 1H, MeCH2N); 3.79–3.85 (m, 
1H, MeCH2N); 3.89–3.95 (m, 1H, MeCH2N); 4.06–4.12 (m, 1H, MeCH2O); 4.19–4.24 
(m, 1H, MeCH2O); 4.40 (dd, 1H, JH,H ≈ 14.0, 7.0, CH2N); 4.63 (dd, 1H, JH,H ≈ 14.0, 8.0, 
CH2N); 4.94 (t, 1H, JH,H ≈ 7.4, CH2CH); 7.08–7.49 (m, 20 arom. CH). 13C-NMR 
(CDCl3): 14.0, 14.7 (2 MeCH2N); 16.2 (MeCH2); 36.6, 38.6 (2 MeCH2N); 41.5 
(CH2CH); 43.3 (CH2N); 61.3 (MeCH2); 125.9, 126.7, 127.8, 127.9, 127.9, 128.3, 128.4, 
128.5, 129.0, 130.3, 130.5, 130.9 (20 arom. CH); 120.9, 121.8, 128.4, 128.5, 129.3, 
131.7, 134.7, 137.3, 142.0 (4 arom. C, 2 C(4), 2 C(5), C(2)); 153.4, 169.6 (2 C=O). HR-
ESI-MS: 611.3020 ([M+H]+, C39H39N4O3+; calc. 611.3016).  
 Ethyl 2-(4,5-Diphenyl-1-propylimidazol-2-yl)-3-(2-oxo-4,5-diphenyl-3-propyl-
imidazol-1-yl)propanoate (9c). Yield: 50 mg (16%). Pale yellow crystals. M.p. 136–
138° (petroleum ether/Et2O). IR (KBr): 3057, 2965, 2934, 2875, 1740 (C=O), 1683 
(C=O), 1603, 1505, 1448, 1403, 1367, 1296, 1227, 1196, 1155, 1073, 1027, 918, 868, 
775, 699, 645, 616, 509. 1H-NMR (CDCl3): 0.65, 0.67 (2t, 6H, JH,H ≈ 7.4, 2 
MeCH2CH2N); 1.23 (t, 3H, JH,H ≈ 7.1, MeCH2O); 3.58–3.84 (m, 8H, 2 MeCH2CH2); 
4.07–4.13 (m, 1H, MeCH2O); 4.17–4.23 (m, 1H, MeCH2O); 4.43 (dd, 1H, JH,H ≈ 14.0, 
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8.0, CH2N); 4.65 (dd, 1H, JH,H ≈ 14.0, 6.7, CH2N); 4.90 (t, 1H, JH,H ≈ 7.4, CH2CH); 
7.07–7.49 (m, 20 arom. CH). 13C-NMR (CDCl3): 11.0 (2 MeCH2CH2N); 14.0 (MeCH2); 
22.5, 24.0 (2 MeCH2CH2N); 41.6 (CH2CH); 43.2, 43.3 (2 MeCH2CH2N); 45.3 (CH2N); 
61.3 (MeCH2); 125.9, 126.8, 127.7, 127.8, 127.9, 128.3, 128.4, 128.5, 128.9, 130.3, 
130.6, 131.0 (20 arom. CH); 121.2, 121.8, 128.7, 129.4, 131.8, 134.7, 137.2, 142.4 (4 
arom. C, 2 C(4), 2 C(5), C(2)); 153.6, 169.6 (2 C=O). HR-ESI-MS: 639.3333 ([M+H]+, 
C41H43N4O3+; calc. 639.3329).  
Ethyl 2-(1-Allyl-4,5-diphenylimidazol-2-yl)-3-(3-allyl-2-oxo-4,5-diphenyl-
imidazol-1-yl)propanoate (9d): Yield: 65 mg (21%). Pale yellow crystals. M.p. 132–
134° (pentane/Et2O). IR (KBr): 3439, 3061, 3025, 2980, 2923, 1734 (C=O), 1694 
(C=O), 1602, 1505, 1445, 1396, 1351, 1256, 1228, 1194, 1161, 1098, 1071, 1028, 944, 
923, 866, 777, 702, 667, 650, 615, 543, 502. 1H-NMR (CDCl3): 1.20 (t, 3H, JH,H ≈ 7.1, 
MeCH2O); 4.05–4.10 (m, 1H, MeCH2O); 4.15–4.20 (m, 1H, MeCH2O); 4.20–4.30 (m, 
2H, NCH2(allyl)); 4.35–4.48 (m, 2H, NCH2(allyl)); 4.43 (dd, 1H, JH,H ≈ 14.0, 7.5, 
CH2N); 4.62 (dd, 1H, JH,H ≈ 14.0, 7.0, CH2N); 4.81–4.85 (m, 2H, CH2=CH); 4.97 (dd, 
1H, JH,H ≈ 10.0, 0.7, CH2=CH); 5.06 (dd, 1H, JH,H ≈ 10.0, 0.7, CH2=CH); 5.09 (t, 1H, 
JH,H ≈ 7.0, CH2CH); 5.73–5.83 (m, 2H, 2 CH2=CH); 7.08–7.45 (m, 20 arom. CH). 13C-
NMR (CDCl3): 14.0 (MeCH2); 41.8 (CH2CH); 43.1, 43.9, 45.8 (3 CH2N); 61.3 (CH2O); 
116.6, 116.8 (2 CH2=CH); 126.0, 126.8, 127.9, 128.01, 128.02, 128.3, 128.4, 128.7, 
128.8, 130.4, 130.6, 131.1, 133.3, 133.4 (2 CH2=CH, 20 arom. CH); 121.3, 121.8, 
128.1, 128.5, 129.0, 129.04, 129.1, 131.3 (4 arom. C, 2 C(4), 2 C(5), C(2)); 153.4, 169.5 
(2 C=O). HR-ESI-MS: 635.3011 ([M+H]+, C41H39N4O3+; calc. 635.3016).  
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4. Dehydration of 3-Hydroxypropanoate 7b. – Experiment A (in the presence of 
Pd(OAc)2). A soln. of 7b (1 mmol) in N-methylpyrrolidone (1 ml) was heated in an oil 
bath at 110° for 1 h in the presence of a catalytic amount (ca. 15 mg) of Pd(OAc)2. After 
this time, the solvent was evaporated by vacuum distillation and the crude mixture was 
separated on prep. TLC plates (SiO2; petroleum ether/AcOEt 3:2) to give ethyl 2-(1-
ethyl-4,5-diphenylimidazol-2-yl)acrylate (11b) as a semi-solid material. This quite 
unstable compound was used for further experiments with no additional purification. 
Yield after chromatographic workup: 240 mg (68%). IR (KBr): 3058, 2963, 2932, 2872, 
1734, 1602, 1506, 1261, 1096, 1024, 803, 773, 696. 1H-NMR (CDCl3): 1.06 (t, JH,H = 
7.2, MeCH2N); 1.36 (t, JH,H = 7.1, MeCH2O); 3.80 (q, JH,H = 7.2, MeCH2N); 4.34 (q, 
JH,H = 7.1, MeCH2O); 6.36, 6.79 (2d, JH,H = 1.4, =CH2); 7.14–7.49 (m, 10 arom. CH). 
13C-NMR (CDCl3): 14.2, 19.9 (2 MeCH2); 39.6 (CH2N); 61.5 (CH2O); 126.2, 126.8, 
128.0, 128.7 129.0, 131.0 (10 arom. CH); 133.9 (C=CH2); 129.4, 131.3, 132.9, 134.5, 
137.7, 142.9 (2 arom. C, C(2), C(4), C(5), C=CH2); 165.3 (C=O). ESI-MS (MeCN; 
C22H22N2O2): 369 (20, [M+Na]+), 347 (100, [M+1])+. HR-EI-MS (70eV): 346.1681 
([M+], C22H22N2O2+; calc. 346.1687). 
Experiment B (in the absence of Pd(OAc)2). A soln. of 7b (1 mmol) in N-
methylpyrrolidone (1 ml) was heated in an oil bath at 110° for 1 h. After this time, the 
solvent was evaporated by vacuum distillation and the crude, oily mixture was analyzed 
by means of 1H-NMR spectroscopy. In this case, 7b was still the main component of the 
crude reaction mixture. 
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5. X-Ray Crystal Structure Determination of 9a (Table and Figure)2). All 
measurements were made on an Agilent Technologies SuperNova area-detector 
diffractometer [14] using MoKα radiation (λ = 0.71073 Å) from a micro-focus X-ray 
source and an Oxford Instruments Cryojet XL cooler. Data reduction was performed 
with CrysAlisPro [14].  The intensities were corrected for Lorentz and polarization 
effects, and an empirical absorption correction using spherical harmonics [14] was 
applied. The space group was uniquely determined by the systematic absences.   
Equivalent reflections were merged.  The data collection and refinement parameters are 
given in the Table.  A view of the molecule is shown in the Figure. The structure was 
solved by direct methods using SHELXS97 [15], which revealed the positions of all non-
H-atoms.  The non-H-atoms were refined anisotropically. All of the H-atoms were 
placed in geometrically calculated positions and refined by using a riding model where 
each H-atom was assigned a fixed isotropic displacement parameter with a value equal 
to 1.2Ueq of its parent C-atom (1.5Ueq for the Me groups).  The refinement of the 
structure was carried out on F2 by using full-matrix least-squares procedures, which 
minimized the function Σw(Fo2 – Fc2)2. A correction for secondary extinction was 
applied. Neutral atom scattering factors for non-H-atoms were taken from [16a], and the 
scattering factors for H-atoms were taken from [17].  Anomalous dispersion effects 
were included in Fc [18]; the values for f' and f" were those of [16b]. The values of the 
mass attenuation coefficients are those of [16c].  The SHELXL97 program [15] was used 
for all calculations. 
                                                          
2) CCDC-859644 contains the supplementary crystallographic data for this paper. These 
data can be obtained free of charge from the Cambridge Crystallographic Data Centre, 
via www.ccdc.cam.ac.uk/data_request/cif. 
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Table.  Crystallographic Data for Compound 9a 
__________________________________________________________________________________ 
  
Crystallized from CH2Cl2/diisopropylether  
Empirical formula C37H34N4O3  
Formula weight [g mol-1] 582.70  
Crystal color, habit colorless, prism  
Crystal dimensions [mm] 0.08 × 0.20 × 0.40  
Temperature [K] 160(1)  
Crystal system monoclinic  
Space group P21/c  
Z 4  
Reflections for cell determination 9701  
2θ range for cell determination [°] 4 – 59  
Unit cell parameters a [Å] 15.5476(6)  
 b [Å] 10.0461(3)  
 c [Å] 19.8750(7)  
 β [°] 95.067(3)  
 V [Å3] 3092.20(19)  
Dx [g cm-3] 1.252  
µ(MoKα) [mm-1] 0.0805  
Scan type ω  
2θ(max) [°] 59.1  
Transmission factors (min; max) 0.731; 1.000  
Total reflections measured 28418  
Symmetry independent reflections 7690  
Reflections with I > 2σ(I) 5820  
Reflections used in refinement 7690  
Parameters refined 401  
Final R(F) [I > 2σ(I) reflections] 0.0447  
 wR(F2) (all data) 0.1160  
Weights: w = [σ2(Fo2) + (0.0484P)2 + 0.9470P]-1 where P = (Fo2 + 2Fc2)/3  
Goodness of fit 1.030  
Secondary extinction coefficient 0.0026(5)  
Final ∆max/σ 0.001  
∆ρ (max; min) [e Å-3] 0.30; -0.20  
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